About 90 percent of the 86 million doses India has administered since mid-January have come from the Serum Institute of India, with the rest accounted for by a domestic vaccine developed by Bharat Biotech, which is also struggling to boost output.
About 90 percent of the 86 million doses India has administered since mid-January have come from the Serum Institute of India, with the rest accounted for by a domestic vaccine developed by Bharat Biotech, which is also struggling to boost output. ...
More Stories
Glenmark Pharmaâs API arm files papers with Sebi to unlock value via IPO
Veterans Unpacked | Biggest role of a CEO is to connect the dots and sometimes override the excel sheet, says Pawan Goenka
Urban-rural retail inflation gap widens